Table 6.
Summary of survivors' characteristics predicting EQ-5D-3L scores* (n=735)
Predictor | Unstandardised coefficients | Standardised coefficients | 95% CI levels for B | R2 | Adjusted R2 | F-test | P value | |||
B | SE | Beta | P value | Lower level | Upper level | |||||
0.058 | 0.051 | 8.907 | 0.0001 | |||||||
Survivor age | −0.013 | 0.006 | −0.076 | 0.043 | −0.025 | 0.000 | ||||
Existing health condition | 0.298 | 0.157 | 0.070 | 0.059 | −0.011 | 0.607 | ||||
Hospital stay for COVID-19 | 0.644 | 0.181 | 0.131 | 0.0001 | 0.288 | 1.001 | ||||
Number of weeks since COVID-19 diagnosis | 0.050 | 0.012 | 0.154 | 0.0001 | 0.027 | 0.073 | ||||
Male gender | −0.471 | 0.169 | −0.101 | 0.005 | −0.802 | −0.139 |
*Multiple regression; B=the slope of the line between the predictor variable and the dependent variable—the larger the number, the more spread out the points are from the regression line; F-test=degree of the linear regression model fitting the data; R2=how well the model fits the data; males=1 and females=0; females are the reference group.
EQ-5D-3L, EuroQol group five dimensions three level.